AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
22 hedge funds and large institutions have $337K invested in Agile Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
86% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 7
Holders
22
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.5K | |
| 2 | +$2.52K | |
| 3 | +$2K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$1.48K |
Top Sellers
| 1 | -$11.3K | |
| 2 | -$10.1K | |
| 3 | -$5.41K | |
| 4 |
Renaissance Technologies
New York
|
-$5K |
| 5 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$3.97K |